Nitazoxanide controls virus viability through its impact on membrane bioenergetics

Area of Science:

• Virology
• Cellular Metabolism
• Pharmacology

Background:

• Viruses rely on host cell energy metabolism for replication.
• Nitazoxanide is known to interfere with cellular energy processes.
• Nitazoxanide is an uncoupler of mitochondrial oxidative phosphorylation (OXPHOS).

Purpose of the Study:

• To test the hypothesis that mitochondrial uncoupling underlies nitazoxanide's antiviral effects.
• To investigate the relationship between the degree of OXPHOS impairment and antiviral efficacy.

Main Methods:

• Virus-releasing cell lines were treated with nitazoxanide, its metabolite tizoxanide, derivative RM4848, and CCCP to induce varying levels of mitochondrial uncoupling.
• Impact on OXPHOS was measured, and infectious viral particle release was quantified.
• Experiments were repeated with high glucose concentrations to assess the role of glycolysis.

Main Results:

• A decrease in infectious viral particle release correlated with the intensity of OXPHOS impact, regardless of the specific uncoupler used.
• Significant antiviral effects were observed even with modest OXPHOS impairment (≤25%).
• The antiviral effect diminished when glycolysis was enhanced with high glucose concentrations.

Conclusions:

• Moderate interference with mitochondrial OXPHOS, leading to ATP use rearrangement, is the likely mechanism for nitazoxanide's antiviral activity.
• Viral particle infectivity appears highly sensitive to these metabolic rearrangements.
• Targeting mitochondrial bioenergetics, with moderate interference, presents a potential therapeutic strategy, distinct from high-level metabolic disruption.